Indonesia's MDI Venture led a $27 million Series B round for SwipeRx, a platform for pharma professionals.
The company originally known as mClinica was incorporated in Singapore in the year 2014). The region had seen a lot of innovation for patients through a proliferation of telemedicine apps and even innovations for doctors, but the pharmacy and its workforce were largely unaddressed.
He claims that SwipeRx has transformed the pharmacy industry and become a one-stop platform for pharmacists to perform all their daily tasks, from education to purchasing to inventory financing in Southeast Asia.
He says that the outfit provides online accredited education, drug information, job listings, discussion boards, and everything else that the community of pharmacists needs to advance professionally and better serve patients.
The SwipeRx app allows users to keep up to date with the latest healthcare news and drug information, as well as access free educational continuing professional development modules, which are mandatory in many Southeast Asian countries. Meralli insists that SwipeRx is the largest provider of online accredited education for pharmacy professionals.
The app can be used to find new job opportunities or to post job offers. The app invites users who aren't necessarily on the verge of changing jobs to expand their network by connecting to their pharmacy peers. It is easy to think of SwipeRx as aLinkedIn and Amazon for pharmacy.
The company has been able to negotiate better prices, as well as launch B2B commerce in the same app, by forming a singular purchasing network. SwipeRX's community-driven commerce model allows small pharmacies to benefit from the power of that broad network by accessing the best prices and better ensuring that medicines are available to them and their patients, he said.
SwipeRX will use the capital to scale its growth across Southeast Asia, expand its logistics network for B2B e- commerce and increase its team.
SwipeRx raised $6.3 million in Series A funding in 2017, and has the kind of momentum that investors like.
More than 235,000 pharmacy professionals and 45,000 pharmacies use the app in Southeast Asia, according to the organization.
More than 8,000 retail pharmacies in Indonesia alone are on SwipeRx, accounting for 25% of all pharmacy transactions, with 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884 888-349-8884
SwipeRx is an image.
The past years have allowed us to further our vision to build the largest pharmacy network in the region.
Donald Wihardja, CEO of MDI Ventures, said that they see great potential and promise in SwipeRx's platform as it strives to address the challenges faced by pharmacies, especially in Indonesia.